| 5′-tetramethylbenzidine | TMB |
| Area under the curve | AUC |
| Cholangiocellular carcinoma | CCA |
| Colorectal Cancer | CRC |
| Confidence Interval | CI |
| Chromogranin A | CgA |
| Enzyme-linked immunosorbent assay | ELISA |
| Grade | G |
| Neuroendocrine carcinoma | NEC |
| Neuroendocrine neoplasm | NEN |
| Neuroendocrine tumors | NET |
| Odds Ratio | OR |
| Overall survival | OS |
| Pancreatic ductal adenocarcinoma | PDAC |
| Peptide receptor radionuclide therapy | PRRT |
| Receiver operating characteristic | ROC |
| Soluble urokinase-type plasminogen activator receptor | suPAR |
| Somatostatin receptor | SSR |
| Temozolomide/Capecitabine | TEM/CAP |
| TNM classification of malignant tumors | TNM |
| Urokinase plasminogen activator receptor | uPAR |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.